Nicholas Glover
President, Chief Executive Officer & Director
Oncology
ProNAi Therapeutics, Inc.
United States of America
Biography
Dr. Nicholas Glover is President, Chief Executive Officer & Director at ProNAi Therapeutics, Inc. and Independent Non-Executive Director at MEI Pharma, Inc. He is on the Board of Directors at ProNAi Therapeutics, Inc. and MEI Pharma, Inc. Dr. Glover was previously employed as President, Chief Executive Officer & Director by YM BioSciences, Inc., President, Chief Executive Officer & Director by Viventia Biotech, Inc., Investment Analyst by University Medical Discoveries, Inc., and an Investment Manager by Lumira Capital Corp. He received his undergraduate degree from the University of East Anglia, a graduate degree from the University of British Columbia, and a doctorate degree from Simon Fraser University.
Research Interest
Oncology
